Lena Basile

Biography

 Dr. Basile founded Neumedicines in 2003 and is the driving force behind its success. Dr. Basile wrote the original IL-12 technology patent applications and secured multiple funded peer-reviewed grants and contracts. To date, Dr. Basile has secured over $70 million in non-dilutive government funding for Neumedicines. Dr. Basile received her doctorate in chemistry from Columbia University in inorganic complex-DNA interactions. She then went on to complete postdoctoral studies at Yale University in the department of Molecular Biology and Biochemistry, where she studied protein-DNA interactions of several DNA-binding proteins including HIV-related proteins. Dr. Basile has over 20 years of scientific experience and also holds a doctorate in law from the University of Houston Law Center. She is a member of the State Bar of California and, prior to founding Neumedicines, practiced as an intellectual property attorney for 7 years.

Research Interest

 Business Management